{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:12:50Z","timestamp":1790665970635,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.acvd.2021.11.005","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T10:50:03Z","timestamp":1643799003000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Marie","family":"Hauguel-Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"A\u00efdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hergault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Beauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Pilli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounir","family":"Ouadahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Josseran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Rab\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mansencal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2021.11.005_bib0205","doi-asserted-by":"crossref","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.acvd.2021.11.005_bib0210","first-page":"744","article-title":"Prevalence and treatment of familial hypercholesterolemia in France","volume":"35","author":"Berard","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0215","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.117.032321","article-title":"Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999\u20132014)","volume":"137","author":"Bucholz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.11.005_bib0220","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.11.005_bib0225","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.11.005_bib0230","doi-asserted-by":"crossref","first-page":"3478a","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ancard.2017.04.015","article-title":"Familial hypercholesterolemia: a largely underestimated cardiovascular risk","volume":"67","author":"Ferrieres","year":"2018","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.acvd.2021.11.005_bib0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/clc.22881","article-title":"Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk","volume":"41","author":"Seguro","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0245","first-page":"e159","article-title":"Familial hypercholesterolemia: an under-diagnosed and under-treated disease. Survey of 495 physicians","volume":"47","author":"Beliard","year":"2018","journal-title":"Presse Med"},{"key":"10.1016\/j.acvd.2021.11.005_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0255","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/joim.12812","article-title":"Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome","volume":"284","author":"Benedek","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.acvd.2021.11.005_bib0265","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOL.0000000000000311","article-title":"Identifying familial hypercholesterolemia in acute coronary syndrome","volume":"27","author":"Gencer","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0270","first-page":"1322","article-title":"Estimating the prevalence of familial hypercholesterolemia in acute coronary syndrome: a systematic review and meta-analysis","volume":"35","author":"Kramer","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0275","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/eurheartj\/ehv289","article-title":"Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes","volume":"36","author":"Nanchen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2016.08.001","article-title":"The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction","volume":"181","author":"Rerup","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0285","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","article-title":"Familial hypercholesterolemia among young adults with myocardial infarction","volume":"73","author":"Singh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0290","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0295","article-title":"Long-term changes of the cardiovascular risk factors and risk scores in a large urban population","author":"Hauguel-Moreau","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0300","doi-asserted-by":"crossref","first-page":"e0124817","DOI":"10.1371\/journal.pone.0124817","article-title":"Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated french urban population: the CARVAR 92 study","volume":"10","author":"Karam","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2021.11.005_bib0305","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acvd.2021.11.005_bib0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bmj.322.7278.111","article-title":"Familial hypercholesterolaemia is underdiagnosed after AMI","volume":"322","author":"Dorsch","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2021.11.005_bib0315","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.11.005_bib0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2021.11.005_bib0325","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1373\/clinchem.2017.279422","article-title":"Imputation of baseline LDL cholesterol concentration in patients with familial hypercholesterolemia on statins or ezetimibe","volume":"64","author":"Ruel","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.acvd.2021.11.005_bib0330","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2021.11.005_bib0335","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.atherosclerosis.2018.06.856","article-title":"Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: results of the EXPLORE-J study","volume":"277","author":"Harada-Shiba","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2021.11.005_bib0340","doi-asserted-by":"crossref","first-page":"352e6","DOI":"10.1016\/j.jacl.2020.03.008","article-title":"Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program","volume":"14","author":"Danchin","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0345","first-page":"2245","article-title":"European Society of Cardiology\/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin\/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk","volume":"38","author":"Landmesser","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0350","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.11.005_bib0355","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.11.005_bib0360","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.11.005_bib0365","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.11.005_bib0370","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long-term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2021.11.005_bib0375","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.acvd.2015.04.003","article-title":"Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population","volume":"108","author":"Seguro","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2021.11.005_bib0380","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2019.08.1002","article-title":"Long-term evolution of premature coronary artery disease","volume":"74","author":"Collet","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0385","doi-asserted-by":"crossref","first-page":"e017712","DOI":"10.1161\/JAHA.120.017712","article-title":"Risk factor burden and long-term prognosis of patients with premature coronary artery disease","volume":"9","author":"Zeitouni","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2021.11.005_bib0390","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacl.2010.08.022","article-title":"Defining the challenges of FH screening for familial hypercholesterolemia","volume":"4","author":"Defesche","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOL.0000000000000496","article-title":"Familial hypercholesterolemia: experience from France","volume":"29","author":"Rabes","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.acvd.2021.11.005_bib0400","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213622000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213622000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:41Z","timestamp":1761745661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213622000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1875213622000146"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2021.11.005","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}